# A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)

> **NCT00231816** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 763 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** ZOSTAVAX™ (concomitant)
- **BIOLOGICAL:** Comparator: Influenza Vaccine
- **BIOLOGICAL:** ZOSTAVAX™ (Nonconcomitant)

## Key facts

- **NCT ID:** NCT00231816
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 763 (ACTUAL)
- **Last updated:** 2015-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231816, "A Study of an Investigational Zoster Vaccine in Subjects With a History of Varicella (Chickenpox) Given Concomitantly With Another Vaccine (V211-011)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00231816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*